NOS2 and Alzheimer disease: AD rats treated with Rehmannioside A have shown a great improvement in cognitive function and memory by promoting neuro growth; the mechanism is partially associated with the inhibition of NOS and superoxide dismutase (SOD) activity (Sun et al., 2014; Sun et al., 2019).